Celldex Therapeutics Inc Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 29 Posts
1 2
Top Picks Mid-Year Updates- Celldex Therapeutics
Article By: MoneyShow.com Sunday, July 4, 2021 12:41 PM EDT
Celldex Therapeutics (CLDX​​​​​​​) remains one of our Top Picks for 2021 with the company delivering value creating data updates so far this year. The stock has risen 53% so far this year.
In this article: CLDX
Read
Stock Charts To Watch - Thursday, June 11
Video By: Harry Boxer Thursday, June 11, 2020 9:16 PM EDT
The Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares (DRIP) popped 79 cents, or 18.8%, to 4.99, with a session high of 5.06, on 22.8 million shares traded.
In this video: CLDX, IZEA, ERI, DRIP
Watch
5 Tiny Biotech Stocks With Superb Growth Potential
Article By: Swarup Gupta Wednesday, February 13, 2019 11:40 AM EDT
After a disastrous end to 2018, pharma stocks have started the New Year on a considerably strong note. Here are several biotech stocks which would be a smart choice to invest in.
In this article: BDSI, CYTK, CLDX, ADRO, AEZS Also: XBI, BMY, CELG, LLY, LOXO
Read
Dow Jones News: Markets Fall As March FOMC Meeting Starts
Article By: Money Morning Tuesday, March 14, 2017 10:46 PM EDT
The Dow fell 44 points as the markets prepare for tomorrow's announcement by the Federal Reserve on whether the central bank will raise interest rates in March.
In this article: BRK-A, CVX, UAL, UPS, VRX, XOM, CLDX, INTC, OIL, USO, SNAP, AAL, MBLY, FOGO, RUBI
Read
E Celldex Announces Discontinuation Of Phase 3 Trial In Patients With Brain Cancer
Article By: Terry Chrisomalis Monday, March 7, 2016 6:04 PM EDT
Celldex abandons trial of Rintega; stock drops 53%. Now it's up to the pipeline.
In this article: CLDX
Read
Biotech And Speculating: A Lot Of Fun… If You Can Handle It
Article By: Marc Lichtenfeld Monday, January 11, 2016 6:10 PM EDT
Biotech has a unique feature. Not only are the potential gains better than in any other sector of the market, but people actually enjoy following the progress of the stocks.
In this article: CLDX, CELG Also: KO, TGT
Read
Five Stocks Searching For A Cancer Cure Right Now
Article By: Arpita Dutt Thursday, October 15, 2015 10:03 AM EDT
With companies working on bringing improved treatments with fewer side effects to market, it may be a good idea to keep an eye on these stocks which have the potential to revolutionize cancer treatment.
In this article: BMY, MRK, CLDX, AMGN, JUNO, KITE, BLUE
Read
2015 Rayno Biopharmaceutical Stock Portfolio
Article By: Rod Raynovich Tuesday, July 14, 2015 9:00 PM EDT
The Biotech Bull Market Is Now in its Sixth Year Led By Biopharmaceuticals. Here is the current Rayno Biopharmaceutical Stock Portfolio as of 7/13 prices
In this article: ALXN, BIIB, CBST, CLDX, FCSC, GILD, OPTR, PCYC, REGN, SGEN, VPHM Also: FBT, IBB, XBI
Read
Biotech Stocks Lose Momentum With Greece Crisis; Blockbuster Immunotherapy Deal
Article By: Rod Raynovich Monday, June 29, 2015 9:56 PM EDT
The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down over 3% faring worse than the NASDAQ down 2.4%.
In this article: ADRO, BLUE, CELG, CLDX, EPZM, IBB, ICPT, JUNO, KITE, QQQ, SRPT, XBI
Read
Cantor Fitzgerald And Brean Capital Positive On Celldex Therapeutics, Inc. Following Positive Data For Brain Tumor Therapy
Article By: TipRanks Monday, June 1, 2015 1:38 PM EDT
Celldex Therapeutics, Inc. shares were up more than 10% in pre-market trading today after the biopharmaceutical company released positive trial results from the Rintega study.
In this article: CLDX
Read
Monday Morning Pre-Market Insights: CLDX, CLDN, CTIC, TGTX
Article By: TipRanks Monday, June 1, 2015 8:46 AM EDT
Monday Morning Pre-Market Insights: CLDX, CLDN, CTIC, TGTX.
In this article: CLDX, CLDN, CTIC, TGTX
Read
Rayno Life Science Stocks Move Higher: CLVS, RHHBY- ASCO Preview
Article By: Rod Raynovich Thursday, May 14, 2015 7:30 PM EDT
CLVS - with a valuation of only $3.4B and three platform products in the pipeline including companion diagnostics the Company is on “hit lists” to be acquired. CLVS was added to the Rayno Portfolio on January 13, 2015 at a price of $60.
In this article: CLVS, RHHBY, ALXN, ALKS, SGEN, VRTX, REGN, GILD, AMGN, CLDX, RXDX, FCSC, XLV Also: BLUE, JUNO, KITE, ZIOP, PBYI, AZN, BMY, CELG, INCY, MDVN, MRK
Read
Hot Biotech Sector: Mid-Caps Have Both M&A And Pipeline Premiums
Article By: Rod Raynovich Wednesday, May 13, 2015 3:26 PM EDT
M&A has been a major driver of bio-pharmaceutical stocks and the buyout of Syngeva by Alexion for $8.4B last week showed that there is a lot of value in pipelines that fit with the acquirer.
In this article: VRX, ARIA, SGEN, ALKS, CLDX, VRTX Also: PCYC, ABBV, MRK, AMGN, GEVA, ACT, SNY, ALNY, FBT, CBST, ALXN
Read
Two Biggest Trends In The Market’s Hottest Sector
Article By: Bret Jensen Monday, April 27, 2015 3:57 AM EDT
The industry we are profiling today has outperformed the overall market for five straight years. A first for any of the 10 major sectors. And, it still has many strong economic tailwinds propelling it higher.
In this article: EGRX, TEVA, HALO, AGEN, PGNX, BLUE, CLDX, KITE
Read
Biotechs Lag In Snap-Back Rally: CAR-T
Article By: Rod Raynovich Monday, April 20, 2015 8:08 PM EDT
This will be a big week for the market with 25% of all S&P companies reporting earnings. The leading sectors are technology, telecom and utilities with healthcare lagging but up 0.4%. Major biotech ETFs are slightly green.
In this article: BLUE, JUNO, KITE, ZIOP, NVS, CLDX, SGEN, CLVS, ADRO, INCY, MRK
Read
Roth Capital Weighs In On 5 Biotech Stocks To Watch
Article By: TipRanks Sunday, April 5, 2015 1:27 PM EDT
As the biotech sector becomes more volatile, analyst Joseph Pantginis of Roth Capital points out that it is increasingly necessary to “focus on names with definitive catalysts.” Though the analyst rates 15 biotech stocks, we have highlighted 5 of them.
In this article: CLDX, BLRX, CRIS, GNVC
Read
1 to 16 of 29 Posts
1 2